STOCK TITAN

Regenerx Biopharmaceuticals (RGRX) Revenue by Year

RGRX

Regenerx Biopharmaceuticals generated $77K in revenue in fiscal year 2022. That is unchanged from the prior fiscal year. Over the trailing 12 months, Q2 FY2022 through Q1 FY2023, the same line adds up to $77K in revenue. The table below carries 13 fiscal years, from 2010 to 2022, and the quarters Regenerx Biopharmaceuticals has filed alongside them.

FY2022 annual
Revenue $77K
YoY 0.0%
5Y CAGR +6.3%
Source SEC Filings (10-K/10-Q) Latest period Q1 FY2023, ended Mar 31, 2023 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

RGRX Revenue by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-KFY1110-KFY1010-K
Revenue$77K$77K0.0%$77K0.0%$77K0.0%$77K+10.2%$70K+23.0%$57K-39.3%$93K+53.9%$61K$0N/AN/AN/AN/A

TTM is the trailing twelve months, Q2 FY2022 through Q1 FY2023, summed from the four most recent quarterly filings.

RGRX Revenue by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ1'2310-QQ4'2210-QQ3'2210-QQ2'2210-QQ1'2210-QQ4'2110-KQ3'2110-QQ2'2110-QQ1'2110-QQ4'2010-KQ3'2010-QQ2'2010-Q
Revenue$19K0.0%$19K0.0%$19K0.0%$19K0.0%$19K0.0%$19K0.0%$19K0.0%$19K0.0%$19K0.0%$19K0.0%$19K0.0%$19K0.0%

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More Regenerx Biopharmaceuticals financials

Frequently Asked Questions

What was Regenerx Biopharmaceuticals's revenue in fiscal year 2022?

Regenerx Biopharmaceuticals generated $77K in revenue in fiscal year 2022.

How fast is Regenerx Biopharmaceuticals's revenue growing?

Regenerx Biopharmaceuticals (RGRX) revenue was essentially unchanged year over year, at $77K in fiscal year 2022 against $77K the year before.

What is Regenerx Biopharmaceuticals's revenue over the last twelve months?

Regenerx Biopharmaceuticals (RGRX) reported $77K in revenue over the trailing 12 months, Q2 FY2022 through Q1 FY2023, summed from the four most recent quarterly filings.

Regenerx Biopharmaceuticals (RGRX) reported $19K in revenue in Q1 2023. That is unchanged from the same quarter a year earlier.

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Regenerx Biopharmaceuticals (RGRX) reported on that line in every period on record.